180698-14-0 Usage
General Description
1-(3,5-difluorophenyl)piperazine is a chemical compound that is composed of a piperazine ring with a 3,5-difluorophenyl group attached to it. It is commonly used as a building block in the synthesis of various pharmaceutical compounds, particularly in the development of central nervous system drugs. 1-(3,5-difluorophenyl)piperazine has been found to exhibit potential psychoactive properties and has been the subject of research in the development of new psychoactive substances. Additionally, 1-(3,5-difluorophenyl)piperazine has been investigated for its potential use in the treatment of certain neurological and psychiatric disorders. It is important to note that this compound may have potential for abuse and misuse, and caution should be taken when handling and using it.
Check Digit Verification of cas no
The CAS Registry Mumber 180698-14-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,0,6,9 and 8 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 180698-14:
(8*1)+(7*8)+(6*0)+(5*6)+(4*9)+(3*8)+(2*1)+(1*4)=160
160 % 10 = 0
So 180698-14-0 is a valid CAS Registry Number.
180698-14-0Relevant articles and documents
LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME
-
, (2021/04/17)
LpxH targeting compounds, compositions thereof, as well as methods for for making and using the same are disclosed herein. The LpxH target compounds typically have a structure pursuant to Formula (I) and/or a salt thereof, wherein Rb is selecte
INHIBITORS OF DIHYDROCERAMIDE DESATURASE FOR TREATING DISEASE
-
, (2019/08/20)
Disclosed herein are dihydroceramide desaturase 1 (Des1) inhibitor compounds and compositions, which are useful in the treatment of diseases, such as metabolic disorders, where inhibition of Des1 is expected to be therapeutic to a patient. Methods of inhibition of Des1 activity in a human or animal subject are also provided.
PYRROLE mTORC INHIBITORS AND USES THEREOF
-
, (2018/05/27)
The present invention provides compounds, compositions thereof, and methods of using the same.